Skip to content

The effect of Tarooneh on pain

A Clinical Trial to Compare the Effects of Oral Tarooneh and Placebo on Patients' Pain after Lumbar surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017063034815N1
Enrollment
70
Registered
2017-09-27
Start date
2017-07-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar pain. Low back pain

Interventions

Intervention 1: Intervention group: Tarooneh, 5 mg, orally, 3 times a day at 6, 12 and 24 hours after surgery. Intervention 2: Control group: Distilled water, 5 mg, orally, 3 times a day at 6, 12 and
Placebo
Intervention group: Tarooneh, 5 mg, orally, 3 times a day at 6, 12 and 24 hours after surgery.
Control group: Distilled water, 5 mg, orally, 3 times a day at 6, 12 and 24 hours after surgery.

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age range 30 to 50 years; Having discopathy without fusion; Not fasting; Does not have a disease that increases or decreases pain; Do not breast-feed or be pregnant;Non-addiction;Specific underlying disease, such as heart disease;Tarooneh insensitivity. Exclusion criteria:Unwillingness to attend the study; Transfer to another department.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: One hour before the intervention and 7,13 and 25 hours after the intervention. Method of measurement: Visual Analog Scale(vas).

Secondary

MeasureTime frame
Blood pressure. Timepoint: One hour before the intervention and 7,13 and 25 hours after the intervention. Method of measurement: Sphygmomanometer.;Temperature. Timepoint: One hour before the intervention and 7,13 and 25 hours after the intervention. Method of measurement: Centimeter using a thermometer.;Heart beat. Timepoint: One hour before the intervention and 7,13 and 25 hours after the intervention. Method of measurement: pulse/min using a Puls Oximeter.;Breathing. Timepoint: One hour before the intervention and 7,13 and 25 hours after the intervention. Method of measurement: respiratory rate/ min by viewing.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra SHahsavari

Arak University of Medical Sciences

www.ararkmu.ac.ir; z.shahsavari@arakmu.ac.ir+98 86 3417 3502

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026